Na Hu, PhD, MBA
About Na Hu, PhD, MBA
Na Hu, PhD, MBA, is the Director and China Pricing Lead for Government Affairs and Market Access at Bristol Myers Squibb in Shanghai, China.
Current Position at Bristol Myers Squibb
Na Hu is currently the Director, China Pricing Lead in Government Affairs and Market Access at Bristol Myers Squibb, based in Shanghai, China. In this role, Na Hu focuses on pricing strategies and market access for biopharmaceutical products within the Chinese market. This position leverages his extensive experience in government affairs, market access, and life sciences consulting.
Previous Role at Guidehouse
Na Hu worked as a Managing Consultant at Guidehouse from 2017 to 2020 in the New York City Metropolitan Area. During his tenure, he played a key role in the integration process when Guidehouse acquired Navigant in October 2019. His experience at Guidehouse contributed significantly to his expertise in consulting and market strategy.
Experience at ZS Associates and FDA
Prior to his role at Guidehouse, Na Hu was a Business Associate Consultant at ZS Associates in Silver Spring, MD, from 2015 to 2016. Additionally, he worked as a Research Assistant at the FDA’s Center for Drug Evaluation and Research (CDER) for 11 months in 2015. These roles provided him with valuable experience in business consulting and drug evaluation research.
Educational Background
Na Hu holds a PhD in Analytical Chemistry from Michigan Technological University, completing his doctorate from 2013 to 2015. He also earned a full-time MBA from The George Washington University, where he studied healthcare and international business. This diverse educational background forms a strong foundation for his work in both the public and private sectors.
Career in Multiple Geographic Locations
Na Hu has worked across various geographic locations, including the US, China, and the Washington D.C. Metro Area. His diverse roles have included a Life Sciences Consultant for the China Practice at Albright Stonebridge Group, an R&D Chemist at Verso Corporation in Wisconsin Rapids, and a Drug Research Intern at Amgen Inc. in the San Francisco Bay Area. This broad exposure has equipped him with a robust understanding of global market dynamics.